61 - 70 out of 4,192Page size: 10
  1. 2022

  2. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

    PRECISION investigators, 3 Dec 2022, In: The Lancet. 400, 10367, p. 1927-1937 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Case report: Recurrent angioedema: Diagnosing the rare and the frequent

    Buttgereit, T., Fijen, L. M., Vera, C., Bergmann, K. C., Maurer, M. & Magerl, M., 2 Dec 2022, In: Frontiers in Medicine. 9, 1048480.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. 89Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer

    Zheng, K. H., Kroon, J., Schoormans, J., Gurney-Champion, O., Meijer, S. L., Gisbertz, S. S., Hulshof, M. C. C. M., Vugts, D. J., van Dongen, G. A. M. S., Coolen, B. F., Verberne, H. J., Nederveen, A. J., Stroes, E. S. G. & van Laarhoven, H. W. M., 1 Dec 2022, In: Journal of nuclear medicine. 63, 12, p. 1880-1886 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. An explorative epigenome-wide association study of plasma renin and aldosterone concentration in a Ghanaian population: the RODAM study

    van der Linden, E. L., Halley, A., Meeks, K. A. C., Chilunga, F., Hayfron-Benjamin, C., Venema, A., van den Berg-Garrelds, I. M., Danser, J. A. H., van den Born, B. J., Henneman, P. & Agyemang, C., 1 Dec 2022, In: Clinical epigenetics. 14, 1, 159.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups

    Georgakis, M. K., Malik, R., Richardson, T. G., Howson, J. M. M., Anderson, C. D., Burgess, S., Hovingh, G. K., Dichgans, M. & Gill, D., 1 Dec 2022, In: BMC medicine. 20, 1, 245.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Can we revive CETP-inhibitors for the prevention of cardiovascular disease?

    Nicholls, S. J., Ray, K. K., Nelson, A. J. & Kastelein, J. J. P., 1 Dec 2022, In: Current opinion in lipidology. 33, 6, p. 319-325 7 p.

    Research output: Contribution to journal › Review article › Academic › peer-review

  8. Consensus and guidelines on lipoprotein(a)-Seeing the forest through the trees

    Kronenberg, F., Mora, S. & Stroes, E. S. G., 1 Dec 2022, In: Current opinion in lipidology. 33, 6, p. 342-352 11 p.

    Research output: Contribution to journal › Review article › Academic › peer-review

  9. Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events

    Meiring, S., Busch, C. B. E., van Baar, A. C. G., Hemke, R., Holleman, F., Nieuwdorp, M. & Bergman, J. J. G. H. M., 1 Dec 2022, In: Cardiovascular diabetology. 21, 1, 191.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Ethnic differences in urinary monocyte chemoattractant protein-1 and heparanase-1 levels in individuals with type 2 diabetes: the HELIUS study

    van der Velden, A. I. M., van den Berg, B. M., van den Born, B. J., Galenkamp, H., Ijpelaar, D. H. T. & Rabelink, T. J., 1 Dec 2022, In: BMJ open diabetes research & care. 10, 6

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Gut microbiome-wide association study of depressive symptoms

    Radjabzadeh, D., Bosch, J. A., Uitterlinden, A. G., Zwinderman, A. H., Ikram, M. A., van Meurs, J. B. J., Luik, A. I., Nieuwdorp, M., Lok, A., van Duijn, C. M., Kraaij, R. & Amin, N., 1 Dec 2022, In: Nature communications. 13, 1, 7128.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1...3 4 5 6 7 8 9 10 ...420 Next

ID: 19892